Eric D. Labonté

835 total citations
14 papers, 678 citations indexed

About

Eric D. Labonté is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Eric D. Labonté has authored 14 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Oncology. Recurrent topics in Eric D. Labonté's work include Cholesterol and Lipid Metabolism (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Eric D. Labonté is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Eric D. Labonté collaborates with scholars based in United States, Canada and Sweden. Eric D. Labonté's co-authors include David Y. Hui, Philip N. Howles, Juan Camilo Rojas Echeverri, Ronald J. Jandacek, Joanna P. Davies, Yiannis A. Ioannou, Dominique Charmot, Luis B. Agellon, Jill Kohler and Andrew Spencer and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Diabetes.

In The Last Decade

Eric D. Labonté

14 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric D. Labonté United States	13	283	264	135	128	120	14	678
Xavier Molero Spain	17	211 0.7×	426 1.6×	44 0.3×	274 2.1×	31 0.3×	42	788
Eileen Sutherland United States	16	292 1.0×	256 1.0×	168 1.2×	415 3.2×	119 1.0×	20	1.0k
Adelheid Kratzer United States	17	302 1.1×	176 0.7×	27 0.2×	105 0.8×	72 0.6×	26	753
H. Heuer Germany	15	224 0.8×	150 0.6×	52 0.4×	137 1.1×	80 0.7×	43	725
Daisuke Honda Japan	12	213 0.8×	59 0.2×	79 0.6×	40 0.3×	39 0.3×	30	609
Nicholas Davidson United States	14	256 0.9×	268 1.0×	57 0.4×	269 2.1×	112 0.9×	21	761
S. Vaja United Kingdom	13	117 0.4×	131 0.5×	74 0.5×	58 0.5×	25 0.2×	33	376
Tommaso Centorrino Italy	12	152 0.5×	309 1.2×	32 0.2×	78 0.6×	18 0.1×	22	618
Harrison M. Penrose United States	12	220 0.8×	51 0.2×	39 0.3×	43 0.3×	44 0.4×	22	473
Lihua Li China	17	306 1.1×	79 0.3×	29 0.2×	27 0.2×	99 0.8×	42	717

Countries citing papers authored by Eric D. Labonté

Since Specialization

Citations

This map shows the geographic impact of Eric D. Labonté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Labonté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Labonté more than expected).

Fields of papers citing papers by Eric D. Labonté

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Labonté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Labonté. The network helps show where Eric D. Labonté may publish in the future.

Co-authorship network of co-authors of Eric D. Labonté

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Labonté. A scholar is included among the top collaborators of Eric D. Labonté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Labonté. Eric D. Labonté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Jacobs, Jeffrey, Michael R. Leadbetter, Noah Bell, et al.. (2022). Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na⁺/H⁺ Exchanger Isoform 3. ACS Medicinal Chemistry Letters. 13(7). 1043–1051. 14 indexed citations

Johansson, Susanne, Maria Leonsson‐Zachrisson, Mikael Knutsson, et al.. (2016). Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders. Clinical Pharmacology in Drug Development. 6(5). 448–456. 16 indexed citations

Spencer, Andrew, Eric D. Labonté, David P. Rosenbaum, et al.. (2014). Intestinal Inhibition of the Na ⁺ /H ⁺ Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na ⁺ Uptake in Humans. Science Translational Medicine. 6(227). 227ra36–227ra36. 126 indexed citations

Labonté, Eric D., Christopher W. Carreras, Michael R. Leadbetter, et al.. (2014). Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD. Journal of the American Society of Nephrology. 26(5). 1138–1149. 86 indexed citations

Spencer, Andrew, Jeffrey Jacobs, Michael R. Leadbetter, et al.. (2011). RDX5791, a First-in-Class Minimally Systemic NHE3 Inhibitor in Clinical Development for CIC and IBS-C, Increases Intestinal Sodium Leading to Enhanced Intestinal Fluid Volume and Transit. Gastroenterology. 140(5). S–99. 13 indexed citations

Labonté, Eric D., Paul T. Pfluger, David G. Kuhel, et al.. (2010). Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A ₂ and diet‐induced obesity. The FASEB Journal. 24(7). 2516–2524. 48 indexed citations

Labonté, Eric D., Juan Camilo Rojas Echeverri, Ronald J. Jandacek, et al.. (2008). Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated andNpc1l1^−/−mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(4). G776–G783. 96 indexed citations

Hui, David Y., Eric D. Labonté, & Philip N. Howles. (2008). Development and Physiological Regulation of Intestinal Lipid Absorption. III. Intestinal transporters and cholesterol absorption. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(4). G839–G843. 60 indexed citations

Labonté, Eric D., Philip N. Howles, Norman A. Granholm, et al.. (2007). Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1771(9). 1132–1139. 57 indexed citations

10.

Gilham, Dean, Eric D. Labonté, Juan Camilo Rojas Echeverri, et al.. (2007). Carboxyl Ester Lipase Deficiency Exacerbates Dietary Lipid Absorption Abnormalities and Resistance to Diet-induced Obesity in Pancreatic Triglyceride Lipase Knockout Mice. Journal of Biological Chemistry. 282(34). 24642–24649. 35 indexed citations

11.

Labonté, Eric D., et al.. (2006). Group 1B Phospholipase A2–Mediated Lysophospholipid Absorption Directly Contributes to Postprandial Hyperglycemia. Diabetes. 55(4). 935–941. 73 indexed citations

12.

Labonté, Eric D., Qianqian Li, Cyril M. Kay, & Luis B. Agellon. (2003). The relative ligand binding preference of the murine ileal lipid binding protein. Protein Expression and Purification. 28(1). 25–33. 17 indexed citations

13.

Torchia, Enrique C., Eric D. Labonté, & Luis B. Agellon. (2001). Separation and Quantitation of Bile Acids Using an Isocratic Solvent System for High Performance Liquid Chromatography Coupled to an Evaporative Light Scattering Detector. Analytical Biochemistry. 298(2). 293–298. 32 indexed citations

14.

Labonté, Eric D., Qianqian Li, & Luis B. Agellon. (2000). Expression of Cholesterol 7α-Hydroxylase Restores Bile Acid Synthesis in McArdle RH7777 Cells. Archives of Biochemistry and Biophysics. 381(2). 273–277. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact